Cargando…
FZD7 regulates BMSCs-mediated protection of CML cells
Inspite of effective treatment with imatinib (IM), chronic myeloid leukemia (CML) is still an incurable disease. Some patients became refractory because of IM resistance. Bone marrow mesenchymal stem cells (BMSCs) have been implicated a role in promoting CML cells' resistance against IM treatme...
Autores principales: | Liu, Na, Zang, Shaolei, Liu, Yan, Wang, Yingqiao, Li, Wei, Liu, Qiang, Ji, Min, Ma, Daoxin, Ji, Chunyan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4868748/ https://www.ncbi.nlm.nih.gov/pubmed/26716419 http://dx.doi.org/10.18632/oncotarget.6742 |
Ejemplares similares
-
Novel Agent Nitidine Chloride Induces Erythroid Differentiation and Apoptosis in CML Cells through c-Myc-miRNAs Axis
por: Liu, Na, et al.
Publicado: (2015) -
Early BCR-ABL1 decline in imatinib-treated patients with chronic myeloid leukemia: results from a multicenter study of the Chinese CML alliance
por: Zhang, Jingru, et al.
Publicado: (2018) -
DEX‐Induced SREBF1 Promotes BMSCs Differentiation into Adipocytes to Attract and Protect Residual T‐Cell Acute Lymphoblastic Leukemia Cells After Chemotherapy
por: Jia, Ruinan, et al.
Publicado: (2023) -
Restoration of miR-23a expression by chidamide sensitizes CML cells to imatinib treatment with concomitant downregulation of CRYAB
por: Zhu, Xunxun, et al.
Publicado: (2022) -
Wnt signaling is involved in 6-benzylthioinosine-induced AML cell differentiation
por: Zang, Shaolei, et al.
Publicado: (2014)